Friday 26 November 2010

Bayrab


Generic Name: rabies immune globulin (Intramuscular route)


RAY-beez i-MUNE GLOB-ue-lin


Commonly used brand name(s)

In the U.S.


  • Bayrab

  • HyperRAB S/D

  • Imogam Rabies-HT

Available Dosage Forms:


  • Solution

Therapeutic Class: Immune Serum


Uses For Bayrab


Rabies immune globulin is used along with rabies vaccine to prevent infection caused by the rabies virus. Rabies immune globulin works by giving your body the antibodies it needs to protect it against the rabies virus. This is called passive protection. This passive protection lasts long enough to protect your body until your body can produce its own antibodies against the rabies virus.


Rabies immune globulin is given to persons who have been exposed (for example, by a bite, scratch, or lick) to an animal that is known, or thought, to have rabies. This is called post-exposure prophylaxis. Rabies immune globulin is used only in persons who have never before received the rabies vaccine.


Rabies infection is a serious, and often fatal, infection. In the U.S., rabies in wild animals, especially raccoons, skunks, and bats, accounts for most cases of rabies passed on to humans, pets, and other domestic animals. In Canada, the animals most often infected with rabies are foxes, skunks, bats, dogs, and cats. Horses, swine, and cattle also have been known to become infected with rabies. In much of the rest of the world, including Latin America, Africa, and Asia, dogs account for most cases of rabies passed on to humans.


If you are being (or will be) treated for a possible rabies infection while traveling outside of the U.S. or Canada, contact your doctor as soon as you return to the U.S. or Canada, since it may be necessary for you to have additional treatment.


Rabies immune globulin is to be administered only by or under the supervision of your doctor or other health care professional.


Before Using Bayrab


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Although there is no specific information comparing use of rabies immune globulin in children with use in other age groups, this medicine is not expected to cause different side effects or problems in children than it does in adults.


Geriatric


Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of rabies immune globulin in the elderly with use in other age groups.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Immunoglobulin A (IgA) deficiencies—Rabies immune globulin may cause an allergic reaction to occur

Proper Use of rabies immune globulin

This section provides information on the proper use of a number of products that contain rabies immune globulin. It may not be specific to Bayrab. Please read with care.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For injection dosage form:
    • For preventing rabies infection:
      • Adults and children—The dose is based on body weight and must be determined by your doctor. The usual dose is 20 International Units (IU) per kilogram (kg) (9.1 IU per pound) of body weight. This medicine is injected into the buttocks (gluteal) muscle and may also be injected around the areas of any wounds caused by the animal with rabies. This medicine is usually used on the first day of your rabies treatment along with the first dose of rabies vaccine. If this medicine is not used on the first day, it may be used any day up through the seventh day of your rabies treatment.



Bayrab Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common
  • Fever

  • pain, soreness, tenderness, or stiffness of the muscles at the place(s) of injection—may last for several hours after the injection(s)

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Bayrab side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Bayrab resources


  • Bayrab Side Effects (in more detail)
  • Bayrab Use in Pregnancy & Breastfeeding
  • Bayrab Drug Interactions
  • Bayrab Support Group
  • 0 Reviews for Bayrab - Add your own review/rating


  • Rabies Immune Globulin Monograph (AHFS DI)



Compare Bayrab with other medications


  • Rabies Prophylaxis

Thursday 25 November 2010

Propiverine




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

G04BD06

CAS registry number (Chemical Abstracts Service)

0060569-19-9

Chemical Formula

C23-H29-N-O3

Molecular Weight

367

Therapeutic Category

Parasympatholytic agent

Chemical Name

Benzeneacetic acid, α-phenyl-α-propoxy-, 1-methyl-4-piperidinyl ester

Foreign Names

  • Propiverinum (Latin)
  • Propiverin (German)
  • Propivérine (French)
  • Propiverina (Spanish)

Generic Names

  • Propiverine (OS: BAN)
  • Propiverine Hydrochloride (OS: BANM, JAN)

Brand Names

  • Balrer
    Nisshin Seiyaku - Yamagata, Japan


  • Benzfore
    Medisa Shinyaku, Japan


  • Bifolvelin
    Choseido Pharmaceutical, Japan


  • Bup-4
    Taiho Yakuhin, Japan


  • Bupverine
    Hyzon Seiyaku, Japan


  • Detrunorm
    Amdipharm, United Kingdom; Apogepha, Luxembourg; Ferring, Ireland; Pharmafrica, South Africa; Schering-Plough, Croatia (Hrvatska); Schering-Plough, Slovenia


  • Mictonetten
    Apogepha, Czech Republic; Apogepha, Germany; Apogepha, Slovakia


  • Mictonorm Uno
    Apogepha, Germany


  • Mictonorm
    Apogepha, Czech Republic; Apogepha, Germany; Apogepha, Luxembourg; Apogepha, Slovakia; Apogepha/Sandoz, Thailand; Dr. F. Frik, Turkey; OM, Portugal; Phapros Tbk, Indonesia; Taisho Yakuhin, Japan; Vianex / BIANEΞ, Greece


  • Noraguard
    Towa Yakuhin, Japan


  • Penifor
    Kyorin Rimedio, Japan


  • Pollarine
    Takata Seiyaku, Japan


  • Propimedac
    Medac, Germany


  • Propive
    Yoshindo, Japan


  • Propiverin AL
    Aliud, Germany


  • Propiverin Hexal
    Hexal, Germany


  • Propiverin Sandoz
    Sandoz, Germany


  • Propiverin-HCl Stada
    Stada, Germany


  • Urecure
    Toa Yakuhin, Japan


  • Urilosin
    Daito, Japan


  • Uronaverine
    Nichi-Iko PharmaceuticalJMA, Japan


  • Urotrol
    Genovate, Taiwan


  • Vancomic
    Taiyo Pharmaceutical, Japan

International Drug Name Search

Glossary

BANBritish Approved Name
BANMBritish Approved Name (Modified)
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday 23 November 2010

Apo-Indapamide




Apo-Indapamide may be available in the countries listed below.


Ingredient matches for Apo-Indapamide



Indapamide

Indapamide is reported as an ingredient of Apo-Indapamide in the following countries:


  • Canada

  • Singapore

International Drug Name Search

Thursday 18 November 2010

Enteramid




Enteramid may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Enteramid



Formosulfathiazole

Formosulfathiazole is reported as an ingredient of Enteramid in the following countries:


  • Poland

Sulfadimidine

Sulfadimidine is reported as an ingredient of Enteramid in the following countries:


  • Poland

Sulfaguanidine

Sulfaguanidine is reported as an ingredient of Enteramid in the following countries:


  • Poland

International Drug Name Search

Sunday 14 November 2010

Alcipro




Alcipro may be available in the countries listed below.


Ingredient matches for Alcipro



Ciprofloxacin

Ciprofloxacin is reported as an ingredient of Alcipro in the following countries:


  • Peru

International Drug Name Search

Friday 5 November 2010

Leprofen




Leprofen may be available in the countries listed below.


Ingredient matches for Leprofen



Anastrozole

Anastrozole is reported as an ingredient of Leprofen in the following countries:


  • Argentina

International Drug Name Search